157 related articles for article (PubMed ID: 24232187)
1. Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers.
Mozer-Lisewska I; Mania A; Kowala-Piaskowska A; Kluk A; Samara H; Pauli A; Żeromski J
Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):153-60. PubMed ID: 24232187
[TBL] [Abstract][Full Text] [Related]
2. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
3. Activation of natural killer cells by hepatitis C virus particles in vitro.
Farag MM; Weigand K; Encke J; Momburg F
Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
[TBL] [Abstract][Full Text] [Related]
4. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C.
Fiore G; Angarano I; Caccetta L; Serrone M; Jirillo E; Schiraldi O; Antonaci S
Eur J Gastroenterol Hepatol; 1997 May; 9(5):491-6. PubMed ID: 9187883
[TBL] [Abstract][Full Text] [Related]
5. Liver-Resident Bystander CD8
Kefalakes H; Horgan XJ; Jung MK; Amanakis G; Kapuria D; Bolte FJ; Kleiner DE; Koh C; Heller T; Rehermann B
Gastroenterology; 2021 Nov; 161(5):1567-1583.e9. PubMed ID: 34302839
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions.
Pernollet M; Jouvin-Marche E; Leroy V; Vigan I; Zarski JP; Marche PN
Clin Exp Immunol; 2002 Dec; 130(3):518-25. PubMed ID: 12452844
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.
Sène D; Levasseur F; Abel M; Lambert M; Camous X; Hernandez C; Pène V; Rosenberg AR; Jouvin-Marche E; Marche PN; Cacoub P; Caillat-Zucman S
PLoS Pathog; 2010 Nov; 6(11):e1001184. PubMed ID: 21085608
[TBL] [Abstract][Full Text] [Related]
9. NK cells prevalence, subsets and function in viral hepatitis C.
Zeromski J; Mozer-Lisewska I; Kaczmarek M; Kowala-Piaskowska A; Sikora J
Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):449-55. PubMed ID: 21972016
[TBL] [Abstract][Full Text] [Related]
10. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
11. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection.
Yonekura K; Ichida T; Sato K; Yamagiwa S; Uchida M; Sugahara S; Ito S; Abo T; Asakura H
Liver; 2000 Oct; 20(5):357-65. PubMed ID: 11092253
[TBL] [Abstract][Full Text] [Related]
12. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
Yoon JC; Lim JB; Park JH; Lee JM
J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
[TBL] [Abstract][Full Text] [Related]
13. [Intrahepatic and peripheral blood lymphocytes during hepatitis C].
Tomasiewicz K; Modrzewska R
Przegl Epidemiol; 2006; 60(4):665-72. PubMed ID: 17682746
[TBL] [Abstract][Full Text] [Related]
14. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
15. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
16. B-cell clonality in the liver of hepatitis C virus-infected patients.
Fan HB; Zhu YF; Chen AS; Zhou MX; Yan FM; Ma XJ; Zhou H
World J Gastroenterol; 2009 Apr; 15(13):1636-40. PubMed ID: 19340908
[TBL] [Abstract][Full Text] [Related]
17. NKG2D: A versatile player in the immune system.
Jelenčić V; Lenartić M; Wensveen FM; Polić B
Immunol Lett; 2017 Sep; 189():48-53. PubMed ID: 28414183
[TBL] [Abstract][Full Text] [Related]
18. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
Huergo-Zapico L; Acebes-Huerta A; Gonzalez-Rodriguez AP; Contesti J; Gonzalez-García E; Payer AR; Villa-Alvarez M; Fernández-Guizán A; López-Soto A; Gonzalez S
PLoS One; 2014; 9(10):e108326. PubMed ID: 25286418
[TBL] [Abstract][Full Text] [Related]
19. NK cells lacking FcεRIγ are associated with reduced liver damage in chronic hepatitis C virus infection.
Oh JS; Ali AK; Kim S; Corsi DJ; Cooper CL; Lee SH
Eur J Immunol; 2016 Apr; 46(4):1020-9. PubMed ID: 26712042
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.
Wolter F; Glässner A; Krämer B; Kokordelis P; Finnemann C; Kaczmarek DJ; Goeser F; Lutz P; Nischalke HD; Strassburg CP; Spengler U; Nattermann J
J Hepatol; 2015 Dec; 63(6):1334-44. PubMed ID: 26297916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
